These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15582439)
1. Amino-substituted heterocycles as isosteres of trans-cinnamides: design and synthesis of heterocyclic biaryl sulfides as potent antagonists of LFA-1/ICAM-1 binding. Wang GT; Wang S; Gentles R; Sowin T; Leitza S; Reilly EB; von Geldern TW Bioorg Med Chem Lett; 2005 Jan; 15(1):195-201. PubMed ID: 15582439 [TBL] [Abstract][Full Text] [Related]
2. QSAR study on some p-arylthio cinnamides as antagonists of biochemical ICAM-1/LFA-1 interaction and ICAM-1/JY-8 cell adhesion in relation to anti-inflammatory activity. Debnath B; Samanta S; Roy K; Jha T Bioorg Med Chem; 2003 Apr; 11(8):1615-9. PubMed ID: 12659746 [TBL] [Abstract][Full Text] [Related]
3. Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 4. Structure-activity relationship of substituents on the benzene ring of the cinnamide. Winn M; Reilly EB; Liu G; Huth JR; Jae HS; Freeman J; Pei Z; Xin Z; Lynch J; Kester J; von Geldern TW; Leitza S; DeVries P; Dickinson R; Mussatto D; Okasinski GF J Med Chem; 2001 Dec; 44(25):4393-403. PubMed ID: 11728185 [TBL] [Abstract][Full Text] [Related]
4. Discovery of potent antagonists of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction. 3. Amide (C-ring) structure-activity relationship and improvement of overall properties of arylthio cinnamides. Pei Z; Xin Z; Liu G; Li Y; Reilly EB; Lubbers NL; Huth JR; Link JT; von Geldern TW; Cox BF; Leitza S; Gao Y; Marsh KC; DeVries P; Okasinski GF J Med Chem; 2001 Aug; 44(18):2913-20. PubMed ID: 11520199 [TBL] [Abstract][Full Text] [Related]
5. Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties. Liu G; Huth JR; Olejniczak ET; Mendoza R; DeVries P; Leitza S; Reilly EB; Okasinski GF; Fesik SW; von Geldern TW J Med Chem; 2001 Apr; 44(8):1202-10. PubMed ID: 11312920 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 1. Identification of an additional binding pocket based on an anilino diaryl sulfide lead. Liu G; Link JT; Pei Z; Reilly EB; Leitza S; Nguyen B; Marsh KC; Okasinski GF; von Geldern TW; Ormes M; Fowler K; Gallatin M J Med Chem; 2000 Oct; 43(21):4025-40. PubMed ID: 11052808 [TBL] [Abstract][Full Text] [Related]
7. Discovery and SAR of diarylsulfide cyclopropylamide LFA-1/ICAM-1 interaction antagonists. Link JT; Sorensen B; Liu G; Pei Z; Reilly EB; Leitza S; Okasinski G Bioorg Med Chem Lett; 2001 Apr; 11(8):973-6. PubMed ID: 11327603 [TBL] [Abstract][Full Text] [Related]
8. Structure of an allosteric inhibitor of LFA-1 bound to the I-domain studied by crystallography, NMR, and calorimetry. Crump MP; Ceska TA; Spyracopoulos L; Henry A; Archibald SC; Alexander R; Taylor RJ; Findlow SC; O'Connell J; Robinson MK; Shock A Biochemistry; 2004 Mar; 43(9):2394-404. PubMed ID: 14992576 [TBL] [Abstract][Full Text] [Related]
9. 1,4-Diazepane-2-ones as novel inhibitors of LFA-1. Wattanasin S; Albert R; Ehrhardt C; Roche D; Sabio M; Hommel U; Welzenbach K; Weitz-Schmidt G Bioorg Med Chem Lett; 2003 Feb; 13(3):499-502. PubMed ID: 12565959 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases. Yusuf-Makagiansar H; Anderson ME; Yakovleva TV; Murray JS; Siahaan TJ Med Res Rev; 2002 Mar; 22(2):146-67. PubMed ID: 11857637 [TBL] [Abstract][Full Text] [Related]
11. Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain. Ullrich T; Baumann K; Welzenbach K; Schmutz S; Camenisch G; Meingassner JG; Weitz-Schmidt G Bioorg Med Chem Lett; 2004 May; 14(10):2483-7. PubMed ID: 15109637 [TBL] [Abstract][Full Text] [Related]
12. Decreasing the expression of LFA-1 and ICAM-1 as the major mechanism for the protective effect of caffeic acid phenethyl ester on ischemia-reperfusion injury. Namazi H J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):550. PubMed ID: 19195957 [No Abstract] [Full Text] [Related]
13. 1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1. Wattanasin S; Kallen J; Myers S; Guo Q; Sabio M; Ehrhardt C; Albert R; Hommel U; Weckbecker G; Welzenbach K; Weitz-Schmidt G Bioorg Med Chem Lett; 2005 Feb; 15(4):1217-20. PubMed ID: 15686945 [TBL] [Abstract][Full Text] [Related]
14. Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1. Keating SM; Clark KR; Stefanich LD; Arellano F; Edwards CP; Bodary SC; Spencer SA; Gadek TR; Marsters JC; Beresini MH Protein Sci; 2006 Feb; 15(2):290-303. PubMed ID: 16384997 [TBL] [Abstract][Full Text] [Related]
15. N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moiety. Burdick DJ; Marsters JC; Aliagas-Martin I; Stanley M; Beresini M; Clark K; McDowell RS; Gadek TR Bioorg Med Chem Lett; 2004 May; 14(9):2055-9. PubMed ID: 15080978 [TBL] [Abstract][Full Text] [Related]
16. Competition between lymphocyte function-associated antigen 1 (CD11a/CD18) and Mac-1 (CD11b/CD18) for binding to intercellular adhesion molecule-1 (CD54). Lub M; van Kooyk Y; Figdor CG J Leukoc Biol; 1996 May; 59(5):648-55. PubMed ID: 8656049 [TBL] [Abstract][Full Text] [Related]
17. Identification of amino acids in the CD11a I-domain important for binding of the leukocyte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1). Edwards CP; Champe M; Gonzalez T; Wessinger ME; Spencer SA; Presta LG; Berman PW; Bodary SC J Biol Chem; 1995 May; 270(21):12635-40. PubMed ID: 7539005 [TBL] [Abstract][Full Text] [Related]
18. Lymphocyte function-associated antigen-1 blockade by statins: molecular basis and biological relevance. Weitz-Schmidt G Endothelium; 2003; 10(1):43-7. PubMed ID: 12699076 [TBL] [Abstract][Full Text] [Related]
19. N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationship. Burdick DJ; Paris K; Weese K; Stanley M; Beresini M; Clark K; McDowell RS; Marsters JC; Gadek TR Bioorg Med Chem Lett; 2003 Mar; 13(6):1015-8. PubMed ID: 12643901 [TBL] [Abstract][Full Text] [Related]
20. Rational design of intercellular adhesion molecule-1 (ICAM-1) variants for antagonizing integrin lymphocyte function-associated antigen-1-dependent adhesion. Song G; Lazar GA; Kortemme T; Shimaoka M; Desjarlais JR; Baker D; Springer TA J Biol Chem; 2006 Feb; 281(8):5042-9. PubMed ID: 16354667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]